News

GlaxoSmithKline (GSK) has obtained Japanese approval for its Encruse Ellipta (umeclidinium). The Japanese Ministry of Health, Labour and Welfare (MHLW) granted approval for the drug to provide relief from various symptoms due to airway obstruction with...

Aduro Biotech has received orphan drug designation from US Food and Drug Administration (FDA) for its immuno-oncology product candidate CRS-207 to treat mesothelioma. Mesothelioma is a form of cancer that affects the smooth layer of mesothelial...

India-based Sun Pharmaceutical Industries has completed the merger with Ranbaxy, as part of a $3.2bn deal. Sun has started integration of the acquired business that allows the firm to become the fifth largest specialty generic pharmaceutical...

Sanofi Pasteur has received approval from US Food and Drug Administration (FDA) for its Quadracel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated Poliovirus; DTaP-IPV) vaccine. The FDA granted approval for the vaccine for...

Agios Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) for its investigational medicine AG-348 to treat pyruvate kinase (PK) deficiency, a rare form of haemolytic anemia. PK deficiency is caused...

AstraZeneca has established a five-year research collaboration with Harvard Stem Cell Institute (HSCI) to adapt a technique that creates human beta cells from stem cells. AstraZeneca will use the technique in its screens of compound library...

The partnership will identify potent, selective and orally bioavailable small molecules that inhibit PTP1B activity in-vivo following stimulation by insulin and leptin to overcome resistance encountered in diabetes and obesity. Under the multi-year deal, CSHL and...